Penelope Felipe Pelczar

Dr. Penelope Felipe Pelczar is a research scientist at the I. Medical Clinic and Polyclinic of the University Medical Center Hamburg-Eppendorf, where she conducts cutting-edge research at the intersection of immunology, gastroenterology, and microbiome science. Her work primarily focuses on understanding the complex interactions between the immune system, gut microbiota, and intestinal inflammation, with particular emphasis on inflammatory bowel diseases, colorectal cancer, and the gut-liver axis. As a key member of the Immunology, immunity, infection (C3i) research group and the Neuro-Immune-Network Hamburg, she collaborates extensively with leading researchers including Samuel Huber and Nicola Gagliani.

Her research interests span multiple domains of mucosal immunology and host-microbe interactions. Dr. Pelczar investigates how T cell subsets, particularly those producing IL-22, regulate intestinal homeostasis and inflammation. She explores the role of cytokines, microbiota-derived metabolites, and epithelial-mesenchymal interactions in diseases like colitis and primary sclerosing cholangitis. Her work on the gut-liver axis has revealed novel mechanisms connecting intestinal inflammation with liver diseases, while her research on microbiome-host interactions has uncovered how bacterial metabolites influence cancer development and treatment response.

Analysis of Dr. Pelczar's publication record from 2016-2025 reveals a consistent trajectory of high-impact research in immunology and gastroenterology. Her work has evolved from foundational studies on IL-22 signaling in inflammatory bowel disease to more complex investigations of the gut-liver axis, microbiome-cancer interactions, and advanced cellular screening techniques. She frequently publishes in top-tier journals including Nature, Science Immunology, and Gastroenterology, demonstrating the significance of her contributions to understanding immune regulation in the gut and its implications for disease pathogenesis and treatment.

While specific awards are not documented in the available information, Dr. Pelczar's extensive publication record in high-impact journals and her leadership roles in collaborative research projects indicate significant recognition within her field. Her work has contributed substantially to our understanding of immune regulation in the gut and its implications for inflammatory diseases and cancer.

Based on her publication record showing consistent collaborations and first/last author positions on significant papers, Dr. Pelczar likely plays an active role in mentoring junior researchers and securing competitive research funding. Her work appears supported by the institutional infrastructure of the University Medical Center Hamburg-Eppendorf, including access to core facilities for proteomics, animal models, and clinical samples. She is likely involved in multiple collaborative research projects investigating immune mechanisms in gastrointestinal diseases.

Dr. Pelczar works within the research ecosystem of the I. Medical Clinic and Polyclinic, which is part of the broader Hamburg research infrastructure including the Hamburg Center of Neuroscience and the Oncological research (UCCH) program. Her work benefits from access to the university's core facilities for proteomics, animal research, and advanced microscopy, enabling her team to conduct sophisticated analyses of immune cell function and host-microbe interactions in health and disease.